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Adenosine receptorThe concept of intra-membrane receptor–receptor interactions (RRIs) between different types of G protein-
coupled receptors (GPCRs) and evidence for their existence was introduced by Agnati and Fuxe in 1980/81
through the biochemical analysis of the effects of neuropeptides on the binding characteristics of monoamine
receptors in membrane preparations from discrete brain regions and functional studies of the interactions
between neuropeptides and monoamines in the control of speciﬁc functions such as motor control and
arterial blood pressure control in animal models.
Whether GPCRs can form high-order structures is still a topic of an intense debate. Increasing evidence,
however, suggests that the hypothesis of the existence of high-order receptor oligomers is correct. A
fundamental consequence of the view describing GPCRs as interacting structures, with the likely formation at
the plasma membrane of receptor aggregates of multiple receptors (Receptor Mosaics) is that it is no longer
possible to describe signal transduction simply as the result of the binding of the chemical signal to its receptor,
but rather as the result of a ﬁltering/integration of chemical signals by the Receptor Mosaics (RMs) and
membrane-associated proteins. Thus, in parallel with experimental research, signiﬁcant efforts were spent in
bioinformatics and mathematical modelling. We review here the main approaches that have been used to
assess the interaction interfaces allowing the assembly of GPCRs and to shed some light on the integrative
functions emerging from the complex behaviour of these RMs. Particular attention was paid to the RMs
generated by adenosineA2A, dopamineD2, cannabinoid CB1, andmetabotropic glutamatemGlu5 receptors (A2A,
D2, CB1 andmGlu5, respectively), and a possible approach tomodel the interplay between the D2–A2A–CB1 and
D2–A2A–mGlu5 trimers is proposed. This article is part of a Special Issue entitled: “Adenosine Receptors”.osine Receptors”.
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The concept of intra-membrane receptor–receptor interactions
(RRIs) between different types of GPCRs and evidence for their
existence was introduced by Agnati and Fuxe in 1980/81 through
analysis of the effects of neuropeptides on the binding character-
istics of monoamine receptors in membrane preparations fromdiscrete brain regions [1–3]. These results were in line with
previous ﬁndings of Limbird et al. [4] showing negative coopera-
tivity in β-adrenergic receptors, which could be explained by the
existence of homodimers leading to site–site interactions. GPCRs are
mainly operating as monomers [5–7], and were found to form and
signal as dimers in several experimental conditions (see [8–12]).
Whether they can form high-order structures is a topic of an
intense debate (see [13]). Increasing evidence, however, suggests
that the hypothesis of the existence of high-order receptor
oligomers is correct (see [14–18]). In particular, by using sequential
resonance energy transfer (SRET) approaches it has been possible to
demonstrate the existence of trivalent GPCRs complexes in living
cells. For instance, the existence of higher-order A2A–CB1–D2 [19]
and A2A–D2–mGlu5 [20] heteromers has been shown. Recently,
another set of studies supported the existence of higher-order
Table 1
Experimental evidence on dimerization/oligomerization of adenosine receptors.
Type of receptors involved Experimental approach Reference
A1/A1 SDS-PAGE [154]
A1/D1 Coimmunoprecipitation [155]
A1/mGluR1α Coimmunoprecipitation [156]
A1/P2Y1 Coimmunoprecipitation [157]
A2A/A2A BRET, FRET [158]
A2A/D2 Coimmunoprecipitation [159]
BRET, FRET [43,160]
A2A/mGluR5 Coimmunoprecipitation [161]
A2A/CB1/D2 BRET, FRET [19,44]
A2A/D2/mGluR5 BiFC, BRET [20]
A2B/D2 (suggested) Changes at signalling level [162]
A3/A3 (suggested) FCS [102]
BRET = bioluminescence resonance energy transfer.
FRET = ﬂuorescence resonance energy transfer.
BiFC = bimolecular ﬂuorescence complementation.
FCS = ﬂuorescence correlation spectroscopy.
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AR), the group of Kobilka has demonstrated that the receptor is
predominantly tetrameric following reconstitution into phospholip-
id vesicles [21]. These authors made also the interesting observation
that binding of inverse agonists leads to signiﬁcant increases in
FRET efﬁciencies for most labelling pairs, suggesting that this class
of ligand promotes tighter packing of protomers and/or the
formation of more complex oligomers by reducing conformational
ﬂuctuations in individual protomers [21].
It is obvious that the hypothesis of high-order GPCR oligomers
implies the existence of speciﬁc interaction interfaces allowing the
assembly of macromolecular complexes. Thus, in parallel with
experimental research, signiﬁcant efforts were spent in bioinfor-
matics to provide suggestions on the protein regions potentially
playing a role in dimerization/oligomerization (see [22,23]).
A fundamental consequence of the view describing GPCRs as
interacting structures, with the likely formation at the plasma
membrane of receptor aggregates of multiple receptors is that it is
no longer possible to describe signal transduction simply as the result
of the binding of the chemical signal to its receptor, but rather as the
result of a ﬁltering/integration of chemical signals in receptor
assemblies.
This point deserves of a comment since, from a theoretical
standpoint, it is possible to surmise that two different situations of
receptor aggregations should be distinguished:
a) Aggregation without the establishment of allosteric interactions
among the GPCRs.
b) Aggregation with the establishment of allosteric interactions
among the GPCRs.
Obviously, only the latter condition is intended when we are
referring to RRIs, which is in turn at the basis of the concept of Receptor
Mosaic (RM). As amatter of fact, the concept of RMhas been introduced
to describe the assemblage of receptors as trimers or high-order
oligomersworking as an integrative input unit (see [24–27] also below).
It should be noted that RMs can interact with membrane-associated
proteins, hence they are usually specialized input units of horizontal
molecular networks (HMNs) that, in turn, are connected with effector
proteins (e.g., enzymes, ion channels) andoperate as complex interfaces
between the extracellular and intracellular environments [26,28]. Aﬁrst
important consequence of such an arrangement is that the decoding
process becomes a branched process already at the receptor level in the
plasma membrane allowing the different activation of some of the
possible intracellular molecular pathways [25,28,29]. A second theoret-
ical consequence is that some engrams can be stored by suitable RMs
and/or HMNs (see [29,30]).
From these premises it follows the relevance of bioinformatics and,
in general, of mathematical approaches capable of shedding some
light on two basic aspects:
a) Structural analysis of GPCRs and membrane-associate proteins to
detect sequences of amino acids or micro-environmental condi-
tions favouring or preventing the formation of RMs and/or of
HMNs hence affecting the complex allosteric interactions taking
place in these macromolecular aggregates [31].
b) Mathematical modelling provides an important tool for the
analysis of the complex cooperative behaviour of receptor
assemblies and to characterize the possible emergence of
integrative functions performed by a receptor aggregate as a
whole [25,32,33].
It should be noted that both of these aspects imply the
fundamental biochemical concept of protein allosterism that has
been recently updated and broadened [34,35] by stating:
- Allosteric perturbations involve a shift of a population of pre-
existing conformations.- Allostery can occur without a change in shape but purely in
dynamics.
- Allosteric signals are communicated along a network of physically
interconnected amino acids residues over a long distance (even
30 Å). Messages between distant sites may be mediated not only
by changes in conformation but also by changes in protein
motions. In other words, both enthalpic and entropic factors
have a role.
Thus, the main bioinformatics approaches to the study of
receptor–receptor interaction, and results provided by mathematical
models on the dynamic behaviour of receptor oligomers will be here
reviewed. A potential important aspect of these analyses is the
possibility they offer to get some hint on the integrative functions of
RMs in the modulation of the release of transmitters allowing
intercellular communication in more or less restricted brain regions.
In particular, in the present paper the possible cross-talk between two
RMs is for the ﬁrst time analyzed by means of a speculative
mathematical model.
Particular attention will be devoted to adenosine receptors, whose
binding thermodynamics was very well characterized (see [36]), and
experimental data exist demonstrating (A1 and A2A subtypes) or
suggesting (A2B and A3 subtypes) their involvement in the formation
of GPCR oligomers. The available experimental evidence on dimer-
ization/oligomerization of adenosine receptors is summarized in
Table 1.
2. Prediction of interaction interfaces
Two modes of association of GPCRs monomers into dimers have
been proposed. One of them is a ‘domain contact’ dimerization
(Fig. 1A), corresponding to the interaction of the molecular surfaces at
speciﬁc binding sites, without largely changing the conformation of
the monomer structure. The other one, termed ‘domain swapping’
dimerization, is amechanism inwhich a substructure (or domain) of a
monomer is exchanged with the corresponding substructure (or
domain) of the other monomer (Fig. 1B). Thus, a large conformational
change of a monomer structure is required for this mechanism (see
[22] for a detailed review). However, in the light of AFM [37], FRET
[38], and, more recently, total internal reﬂection ﬂuorescence
microscopy [12] studies, the ‘domain contact’ is presently considered
as the main mechanism of GPCR dimerization.
Regardless of the type of geometry assumed for the association,
the speciﬁc interacting residues that form the dimerization interface
represent a signiﬁcant target of research in receptor–receptor
Fig. 1.Modes of association of GPCRs monomers into dimers. A. Contact dimer, in which
the interaction interface involves surface contact between helices of the twomonomers
(shown with different shades of grey). B. Domain swapped dimer, in which helices 6
and 7 are exchanged between GPCR monomers.
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only which GPCRs can exhibit signiﬁcant interactions, but inﬂuences
models for potential allosteric interactions between partners. As
anticipated by our group [39,40] evidence to date suggests that
distinctive interaction interfaces or domains are possible both within
the transmembrane helices [41–44] as well as at either the
extracellular amino terminus [45,46] or in the intracellular domains
[43,44] depending on the GPCR.
Furthermore, recently the hypothesis has been put forward that at
the receptor interfaces ‘check-points’ may exist along the amino acid
pathways that, as the Nussinov's group pointed out, allow allosteric
interactions [34]. These check-points are supposed to consist of few
amino acids and to be crucial bottle-necks in transmitting the
allosteric message from one receptor binding site to the other
receptor binding site [28]. As far as GPCRs are concerned, Süel et al.
[47] identiﬁed ten key positions representing the core of a network
(involving 47 AA) of van der Waals interactions linking distant
regions of the molecule. In adenosine receptors (all subtypes) these
positions are located in the transmembrane helices (from TM2 to
TM7), and in intracellular loop 2 and C-terminal domains.
It is, therefore, straightforward the potential importance of the
several bioinformaticsmethods that have been in recent years devised
to predict the interfaces available to a given GPCR for receptor–
receptor interaction and the relevance of the investigations still to be
carried out to detect the putative ‘allosteric pathways’ allowing RRIs.
All of these analyses only provide suggestions that should be
conﬁrmed by experimental data since these studies, in general, do not
consider several variables such as the micro-environment where the
GPCRs are localized. The biophysical properties of specialized
membrane micro-domains (e.g., the Lipid Rafts) can have strong
inﬂuences on the three-dimensional structure of the GPCRs as well as
on the electrostatic interactions between the interacting domains
[26].
The bioinformatics methods here reviewed can, in principle, be
categorized into two broad classes, according to the type of input data
used to perform the analysis:
- Analysis of sequence data. Thus, an analysis of special biophysical
characteristics of the amino acid sequence of the protein under
scrutiny, to identify sites potentially involved in an interaction.
- Analysis of structure data. Thus an analysis of the 3-dimensional
structure of the protein under scrutiny to better deﬁne the possible
surfaces for interactions with other proteins or lipids.
Let us review the main aspects of these two topics with the main
focus on GPCRs and in particular A2A adenosine receptors and their
interactions with D2, mGlu5 and CB1.
2.1. Analysis of sequence data
The ﬁrst approach to deduce the interaction interfaces is usually
the identiﬁcation of protein regions exhibiting some property,
potentially relevant for the interaction with other proteins, that can
be deduced simply by the analysis of the primary structure (i.e. the
amino acid sequence). As far as RRIs are concerned the following
protein features were investigated with an approach of this type.2.1.1. Intrinsic disorder
Over the past decade, the paradigm that proteins function by
adopting highly ordered structures has been challenged by the
observation that thousand of different proteins are likely to be
intrinsically disordered (i.e. lacking a clear-cut secondary structure)
or have intrinsically disordered (ID) domains under native condi-
tions [48,49]. Interestingly, transcription factors and other allosteric
cell signalling proteins (such as the steroid hormone receptors [50])
contain a disproportionate number of domains or segments that are
ID. In many cases folding of these segments is coupled to binding with
one or more of their interaction partners, suggesting that intrinsic
disorder plays an important functional role in protein–protein
interaction, making a protein suitable for different and multiple
interactions. Furthermore, a recent mathematical model [51] showed
that in a single protein with two binding sites, site-to-site allosteric
coupling could be maximized when intrinsic disorder is present in the
domains or segments containing one or both of the coupled binding
sites Thus, disordered domains could be also involved in RRI, and
could represent a signiﬁcant component [52] of the interaction
interfaces leading to the assemblage of receptor dimers and high-
order oligomers, hence of the so-called receptor mosaics as deﬁned by
Agnati and Fuxe and discussed also above (see [24–27]).
Disordered regions of a protein can be identiﬁed using different
features of the amino acid (AA) sequence (see [53] for a more detailed
discussion):
• Sequence composition. ID protein sequences generally have a biased
AA composition and the following empirical rule was established
[48,54]:
- disorder-promoting AA: G, S, and P
- order-promoting AA: W, F, I, Y, V, and L, the remaining AA are
considered neutral as far as the order versus disorder-promoting
effect.
• Secondary structure content. Regions devoid of predicted secondary
structure elements (as judged by a combination of methods) are
generally disordered.
• Sequence complexity. Low complexity regions are regions making
use of fewer types of AA (i.e. they exhibit homopolymeric runs,
short-period repeats and overrepresentation of few residues). ID
proteins tend to have a low sequence complexity.
• Evolutionary sequence variability. From an evolutionary point of
view, disordered regions are on average much more variable than
ordered ones [55].
Using the sequence features mentioned above, several methods
have been developed to classify whether any given residue was in a
disordered region, and the reliability of disorder predictions beneﬁts
from the use of multiple methods [53]. As far as GPCRs are concerned,
Agnati et al. introduced a Disorder index [52] as the weighted average
of the results provided by 10 predictors, whose main characteristics
are summarized in Table 2. As illustrated, the chosen set of predictors
covered a wide spectrum of the strategies at present proposed to
identify disordered regions in proteins using their primary structure.
Examples of this analysis, concerning the different subtypes of
adenosine receptors, are shown in Fig. 2A. It indicated the intracellular
loop 3 and the C-terminal domains as potential sites of interaction
interfaces for A1 and A2A adenosine receptors, a result consistent
with available experimental data (see [43,56–58]). In A2B and A3
subtypes only the C-terminal domain exhibited a signiﬁcant degree of
intrinsic disorder.
GPCRs, however, are complex multi-domain proteins in which
ﬂexible and malleable domains (such as the intra- and extracellular
loops) alternate with well structured transmembrane domains (TM
helices). Thus, the analysis of disordered domains doesn't help for the
identiﬁcation of putative interaction sites located in the TM helices,
and has to be integrated with other methods.
Table 2
Predictors composing the Disorder Index according to Agnati et al. [52].
Predictor Description Reference Web server
GlobPlot Prediction based on Russell–Linding propensities [54] http://globplot.embl.de
B-factor 3.5sd Prediction based on B-Factor deviations greater
than 3.5 std from the overall mean
[54] http://globplot.embl.de
B-factor 2.0sd Prediction based on B-Factor deviations greater
than 2.0 std from the overall mean
[54] http://globplot.embl.de
VLXT Integrates three neural networks: the VL1 predictor
[163], the N-terminus predictor (XN), and the
C-terminus predictor (XC) (both from [164])
[163,164] http://www.pondr.com
XL1_XT A neural network optimized to predict regions of
disorder greater than 39 amino acids, combined
with the abovementioned XN and XC predictors
(collectively called XT).
[164,165] http://www.pondr.com
CAN_XT A neural network that was trained on regions of
13 calcineurin proteins, combined with the
abovementioned XT predictor
[163,164] http://www.pondr.com
VL3 Neural network based tool, trained on 20 attributes
(18 amino acid frequencies, average ﬂexibility and
sequence complexity)
[166] http://www.pondr.com
Spritz SD Support vector machine trained on a collection of
short disordered sequence fragments
[167] http://protein.cribi.unipd.it/spritz/
Spritz LD Support vector machine trained on a set of disordered
sequences, each with over 45 disordered residues
[167] http://protein.cribi.unipd.it/spritz/
POODLE-W Semi-supervised method based on Joachim's spectral
graph transducer algorithm [168]
[169] http://mbs.cbrc.jp/poodle/poodle-w.html
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A possible strategy to overcome the abovementioned limitation in
the evaluation of the interaction sites in TM helices has been proposed
by Agnati, Guidolin et al. (see [59]). This approach is based on the
observation that disordered proteins are less prone to aggregation
compared to structured proteins and the propensity to aggregation
can be evaluated [60,61]. Thus, an Aggregation Index (AI) has been
proposed [59] that can lead to a prediction of potential interaction
interfaces located in the ordered domains of a GPCR. The AI is derived
by the individual aggregation propensities of natural AA as devised byFig. 2. A. Per-residue analysis of disorder in adenosine receptors according to Agnati et a
sequences are present. In A1 and A2A receptor subtypes they are located in the intracellular lo
exhibits a signiﬁcant degree of intrinsic disorder. B. Predicted interaction interfaces of the
bovine rhodopsin (used as a template for class A GPCRs). Potential interfaces in the transme
Table 2). In black are emphasized the potential interfaces located in ICL3 and C-term as sugSànchez de Groot et al. [62], allowing the identiﬁcation of protein
regions that are especially relevant for protein aggregation (‘hot
spots’) by simply analyzing the AA sequence (see [63]).
When applied to the analysis of GPCRs, such as adenosine A2A,
dopamine D2, cannabinoid CB1 and glutamate mGlu5, this approach
predicted “hot spots” in speciﬁc regions of TMs 4–6 [59].
2.1.3. Multiple sequence alignment
A second, and most widely followed, strategy involves bioinfor-
matics methods based on sequence and genomic information tol. [52]. The plot clearly indicates the regions (Disorder index N0.5) where disordered
op 3 (IL3) and in the C-terminal domain, while in A2B and A3 only the C-terminal domain
A2A adenosine receptor according to Agnati et al. [33], mapped on the 3D structure of
mbrane helices (shown in dark grey) were estimated using the GRIP method ([84], see
gested by the analysis of the intrinsic disorder (see above).
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take advantage of the evolutionary relation that exists among GPCRs,
as expressed in their sequences and measurable in the common
elements of their structural and functional features. The underlying
principles of these methods were extensively reviewed by Filizola and
Weinstein [23] and will be here only summarized.
a. The evolutionary trace method. This method is an adaptation of an
early strategy for the hierarchical analysis of residue conservation
in protein sequence alignments [64]. It was ﬁrst described by
Lichtarge et al. [65] as a technique that predicts functionally
important residues (e.g. active sites and functional interfaces) in
proteins. The set of assumptions used to extract such evolutionary
trace residues from sequence conservation patterns in homolo-
gous proteins includes the following: (i) protein structures
descendant from a common ancestor retain their fold, as well as
the location of their functional sites, and (ii) functionally
important residues undergo fewer mutations than other residues
and their lower mutation rate is interrupted mainly by mutations
that cause divergence. Thus, using a phylogenetic tree (or
dendrogram) to represent a multiple sequence alignment of
homologous proteins, an evolutionary trace residue can be
identiﬁed as a residue which, upon partitioning of the tree at a
certain level of sequence divergence, is conserved within each
group into which the dendrogram is divided, but may vary from
one group to another.
b. ‘Level entropy’ and ‘SequenceSpace automation’ methods. As in the
above described approach, these methods [66] use the division of
protein families into subfamilies in the search for those positions
(“tree-determinant residues”) that are conserved within a sub-
family, but differ between subfamilies. They, however, address the
question concerning the best division of a protein family into
subfamilies, or the accurate detection of sequence variation
patterns characteristic of different subfamilies, by using automatic
criteria and procedures. The ﬁrst method takes as a starting point a
phylogenetic representation of a protein family and, following the
principle of relative entropy from information theory [67],
automatically searches for the optimal division of the family into
subfamilies. The secondmethod is an automation of the analysis of
distribution of sequences and amino acid positions in the
corresponding multidimensional spaces using a vector-based
principal component analysis.
c. Correlated mutation analysis (CMA). Correlated mutations are
typically identiﬁed in multiple sequence alignments as loci that
mutate simultaneously. A correlated mutation algorithm was
described by Gobel et al. [68] as a powerful tool to correctly
predict physical contacts in homologous proteins, and Oliveira et
al. [69] used a similar approach to ﬁrst determine the correlation
between residue position in GPCRs. The observation that the type
of compensatory changes identiﬁed by CMA tend to accumulate at
protein interfaces [70] led to the extension of the concept of
correlated mutations to predict protein–protein contacts. This
approach is based on the concept that sequence changes occurring
during evolution at one of the interaction interfaces must be
compensated by changes in the other interacting protein in order
to preserve the protein–protein interface. An improved CMA-
based algorithm was also proposed [71] that combines correlated
mutations with other types of sequence properties, and the
approach was further enhanced with ﬁltering algorithms to enable
identiﬁcation of the likely hetero- and homo-oligomerization
interfaces of family A GPCRs [72].
The various computational studies that looked for possible
dimerization/oligomerization interfaces of GPCRs, using the type of
bioinformatics approaches described above, did not predict exactly
the same interfaces for all the GPCR subfamilies studied. This is not
surprising, given the differences not only in methodology, but also inthe sets of sequences selected for the analysis. However, it is
noteworthy that some domains appear more often than others in
the prediction of GPCR interfaces. According to a meta-analysis
reported by Filizola and Weinstein [23], most of the identiﬁed
residues are within TM4, TM5, and TM6, suggesting a speciﬁc role
for these three helices in dimerization/oligomerization interfaces of
GPCRs.
2.1.4. Triplet homology
Very recently, Tarakanov and Fuxe [73] considered the experi-
mentally conﬁrmed by today 48 pairs of receptors that form or do not
form heterodimers, and, from such an experimental evidence, the
authors deduced by a mathematical approach a set of triplet
homologies that may be responsible for receptor–receptor interac-
tions and might be utilized to construct a kind of code that predicts
which receptors should or should not form heterodimers. Interest-
ingly, such triplets resulted mainly located in the experimentally
conﬁrmed receptor interfaces. An example is provided by the
adenosine receptor A2A, in which some of these triplets can be
found in molecular regions, such as TM4, IL3 and C-terminal domains,
which have been experimentally demonstrated to be involved in the
interaction with other GPCRs [43]. It is also noteworthy that
interaction interfaces predicted by other bioinformatic methods (see
[33]) are characterized by the presence of several of these AA triplets.
Most of them are leucine-rich motifs. Another minor type of triplets
contains charged amino acids. For example, arginine can importantly
contribute to the formation of sequential strong arginine-phosphate
electrostatic bonds with dynamic properties [74,75], as in the
adenosine A2A and dopamine D2 receptor heterodimer [56].
2.2. Analysis of structure data
Although quite powerful in identifying residues that could be
functionally essential for a RRI, the bioinformatic tools based on the
analysis of the AA sequence often don't achieve a speciﬁc identiﬁca-
tion of the interaction interfaces, tending to provide a number of “false
positives”. Consequently, additional stringency criteria must be added
[76], and the data have to be organized in a structural context, i.e.
combined with the available information on the 3D structure of the
proteins under examination. When the tertiary structure is known,
there have been many efforts to predict protein–protein interaction
sites based on the direct analysis of the protein surface properties, and
a number of software tools have been devised (see [77]). They are
summarized in Table 3.
Such an identiﬁcation of the putative active sites of the protein
surface is also a preliminary important step to build models of dimers/
oligomers by using bioinformatic approaches generally known as
‘docking methods’ (see [78] for a review).
2.2.1. Molecular models of GPCRs
As far as GPCRs are concerned, accurate information about their 3D
structure is limited to the rhodopsin-like receptors, forming the class
A of GPCRs, which is by far the largest family of GPCRs.
In fact, coordinate data of bovine rhodopsin are available [79], and
the ﬁrst three-dimensional crystal structure of a transmitter regulated
GPCR, the β2-adrenergic receptor (also belonging to class A), was
published in 2007 by the Kobilka group [80]. The work on high
resolution crystallography of four GPCR structures in the inactive state
shows the high degree of overlap of rhodopsin, β2- and β1-adrenergic
receptors as well as adenosine A2A receptors indicating that class A
receptors have a similar structure [81].
Thus, the as yet solved receptor structures represent important
templates for the bioinformatic analysis of class A GPCRs.
In particular, they make more reliable the informatic methods
based on molecular dynamics simulations on GPCRs in the absence of
ligand and in the presence of antagonist, partial agonist, and full
Table 3
The different properties used in structure-based predictors of protein–protein interaction.
Method Sequence analysis 3D reference structure Geometric features Physical–chemical features Reference Web server
PPI-PRED Yes User PDB ﬁle Yes Electrostatics Hydrophobicity [170] http://bmbpcu36.leeds.ac.uk/ppi_pred/
PINUP Yes User PDB ﬁle No Solvent accessibility [171] http://sparks.informatics.iupui.edu/PINUP/
PPISP Yes User PDB ﬁle No Solvent accessibility [172] http://pipe.scs.fsu.edu/ppisp.html
Promate Yes User PDB ﬁle Yes No [173] http://bioinfo.weizmann.ac.il/promate/
SPPIDER No User PDB ﬁle No Solvent accessibility [174] http://sppider.cchmc.org
GRIP Yes Rhodopsin Yes No [84] http://grip.cbrc.jp/GRIP/
β1AR
β2AR
PDB ﬁle: Protein Data Bank ﬁle format.
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in response to the individual atomic forces arising between the ligand
and the receptor. These regions, indeed, could be involved not only in
receptor activation but also in dimerization/oligomerization [22].Table 4
Interaction surfaces predicted by bioinformatic methods and experimental ﬁndings.
Receptor Predicted Experimental
Location Reference Location Reference
Adenosine A2A TM4, IL3, TM6,
C-term
[33] TM4, IL3,
C-term
[43]
TM5, C-term [44] C-term [175]
TM5 [44,176]
Dopamine D2 TM4 [84] TM4 [85] [110]
TM4, TM5, IL3 [33] TM4, TM5, IL3,
C-term
[43]
TM5, IL3 [44] TM5, IL3 [44]
Cannabinoid
receptor 1
IL3, TM6, C-term [33] IL3, C-term [44]
IL3, C-term [44]
Adrenergic β2 TM6 [84] TM6 [177]
Muscarinic M3 TM4, IL3 [84] 140C, 220C [178]
IL3 [179]
Chemokine receptor 5 TM1, TM4 [180] TM1, TM4 [180]
Rhodopsin TM4, TM5 [84] TM4, TM5 [37,181]2.2.2. Interaction interfaces according to bioinformatic predictors based
on structure data
By using molecular dynamics simulations integrated by data from
CMA and evolutionary trace analysis, Gouldson et al. [22] indicated
transmembrane helices V and VI as key elements of the dimerization
interface between GPCRs, and suggested the possibility of domain
swapping as a mechanism for dimer formation. These simulations,
however, were restricted to the helical part of the receptors and
carried out on homology models of a GPCR, which are generally of
quite limited accuracy.
A pioneering work for the interface prediction of GPCR oligomers
was made by Dean et al., [82]. They applied the evolutionary trace
method to class A, B, and C GPCRs, and identiﬁed two interaction sites
on the tertiary structure (on helices V and VI, and on helices II and III,
respectively). The prediction by Dean et al. agreed with the results of
experiments to some extent. However, deviations of the prediction
from the experimental results have been observed at the same time.
One of the possible reasons why the analysis did not always agree
with the experiments may be that it did not distinguish the subtypes
of GPCRs.
Predictions of the likely hetero- and homo-oligomerization
interfaces of family A GPCRs were obtained by Filizola and co-authors
[23,72], using a CMA enhanced algorithm and the structural
information from the rhodopsin crystal structure. The results
identiﬁed TM1 and TM4 most often as putative interfaces among
the studied GPCRs.
As far as the A3 adenosine receptor was concerned, a study by Kim
and Jacobson [83] predicted a TM4–TM5 dimerization interface as the
most favourable. This contact surface also showed a high degree of
shape complementarity.
Evolutionary trace method in combination with structure data of
bovine rhodopsin was used by Nemoto and Toh [84] to examine some
families of class A GPCRs, including the opsin family, the dopamine
receptor family, the adrenergic receptor family, and the muscarinic
acetylcholine receptor family. The same approach was recently
followed by our group [33] to analyze the dopamine D2, adenosine
A2A, and cannabinoid CB1 receptors. In this study, to estimate the
highest conserved residues of each analyzed protein, 86 sequences of
the dopamine receptor family, 25 sequences of the adenosine receptor
family, and 15 sequences of the cannabinoid receptor family were
used. The results of the analysis of sequence data were then organized
in the context of the rhodopsin tertiary structure by using the GRIP
tool (see Table 3). Furthermore, to better account for the potential
interaction interfaces localized in the highly ﬂexible hydrophilic
domains, regions exhibiting a “disorder index” N0.50 were also
accepted as potential interaction sites. The predicted interfaces for the
adenosine A2A receptor are shown in Fig. 2B.A schematic comparison between the results provided by the
abovementioned bioinformatic analyses and the available experi-
mental data is reported in Table 4. It is noteworthy that both
bioinformatic predictions and experimental data indicate that a GPCR
can exploit multiple interaction interfaces, opening the possibility
that the assemblage of the receptor molecules to form an oligomer
could occur in a number of different geometrical arrangements
(see [33]).
2.3. The D2–A2A–CB1 heteromer
As an example, we shall here consider the heteromer formed by
A2A, D2, and CB1 receptors, which was recently demonstrated in living
cells with the SRET technique [19].
As shown in Table 4, the obtained predictions concerning the
interaction interfaces present in the GPCRs considered here are in
substantial agreement with available experimental data. Consistent
with reported data [43,85], they indicate the presence of potential
interaction surfaces in both the intra-membrane portion of the
molecules (in particular at the level of TM4, TM5, and TM6) and in
the intracellular loops (in particular IL3 and C-terminal). Based on
these results it has been suggested [33] that, from a topological point
of view, at least two types of arrangements could be surmised:
a) Closed loop topology. This hypothesis is based on the observation
[43] that the intracellular domains IL3 and C-term play a key role
in the heterodimerization of A2A and D2. This ﬁnding, together
with the results of the bioinformatic analyses, suggests that the
trimer D2–A2A–CB1 could be arranged as a ring of receptor
molecules with the IL3 domain of each monomer linking the C-
terminal of another one.
b) Linear topology. A compilation of the most frequently observed
GPCR oligomerization interfaces points to speciﬁc regions of TMs
4–6 [85,86]. These domains were also predicted by the
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receptors here considered. Thus, for the trimer D2–A2A–CB1 it
could also be surmised a topology in which the three receptors are
arranged in a linear cluster, for instance through asymmetrical
TM5-TM4 and IL3-C-term interactions between D2 and A2A and
TM6–TM6 interactions between D2 and CB1. A more complex
linear arrangement is based on the possibility for D2 receptors to
form homodimers by TM4–TM4 interactions (see [85]) and then
tetramers by using a second interface in TM5. Additional interfaces
present in the tetramer could be exploited to interact with A2A and
CB1 receptors leading to a higher-order heteroligomer.
The bioinformatic approaches here reviewed do not allow the
identiﬁcation of the true arrangement a RM will assume. In fact, the
most favourable topology will depend on a number of more speciﬁc
conditions including physical properties of the interacting molecules
(surface charge, hydrophobicity etc.) and of the environment
surrounding the interacting proteins (energy landscape). Thus, more
speciﬁc bioinformatics and experimental work would be needed to
elucidate the most probable topology taken by RM in speciﬁed
conditions. In this respect, very recently obtained experimental data
[44], seem to demonstrate that D2–A2A–CB1 heteromers with closed
loop topology actually occur in living cells. It should be noted that the
triangular model is a particular case of the ring model (see
Section 4.1), which has been proposed by Agnati, Guidolin and Fuxe
in the past, and, in the frame of mathematical modeling, the possible
functional implications of such topology for learning and memory
have been discussed [25,26,87].
A further interesting suggestion on the D2–A2A–CB1 heteromer
comes from a bioinformatic analysis aimed at estimating the degree of
similarity of the three receptors in terms of their propensity to
establish protein–protein interactions (see [33]). In this study, a
Disorder index (see Section 2.1.1), an Aggregation index (see
Section 2.1.2), and a Hydropathy index (estimated using the Eisenberg
consensus scale [88], and representing the hydrophobic or hydro-
philic properties of an AA sequence) were evaluated over the
sequences corresponding to the extracellular, transmembrane and
intracellular region of each receptor. Thus, each analyzed GPCR was
characterized with a multivariate set of nine parameters expressing
its propensity to establish protein–protein interactions. To evaluate
the similarity of the considered GPCRs in terms of the chosen
parameters three multivariate distance metrics (Euclidean, Canberra
and Chebyshev distances) were evaluated [89], from which a single
index of the similarity/dissimilarity between the receptor proteins
was derived. Adenosine A2A receptors were those showing the largest
distance from all the other receptors and it was suggested that in the
D2–A2A–CB1 heteromer they might represent intelligent and/or
passive hubs, transmitting the information received to CB1 and D2.
3. Modelling receptor oligomerization and clustering
Receptor clustering has been analyzed by mathematical modelling
for a quite long time (see [90,91]). However, clustering and oligomer-
ization due to an interaction between nearest-neighbour receptor
molecules were not addressed in the early models of receptor
clustering. In fact, they were mainly focused on mechanisms like
“collision coupling” [92], in which receptor–ligand complexes may act
as mobile catalysts for the activation of other proteins in the plasma
membrane, or “receptor cross-linking”, due to the binding of multiple
receptors to a single ligand. Only more recently a few models took into
account RRI as a physical mechanism leading to the self-organization of
receptors in macromolecular complexes at the plasmamembrane level.
A thermodynamic model for receptor clustering including RRI was
proposed by Guo and Levine [93]. In this model, the cell membrane was
treated as a lattice with a spacing on the order of few nanometers. Each
lattice site has either one or zero receptor molecules and each receptorcan be liganded or unliganded. The effective energy function (Hamil-
tonian) of the systemwas composed of two main contributions: a term
due to the binding energies between ligand and receptors, and the
receptor–receptor interaction term. Computer simulations were then
performed in which at each step a random receptor was chosen and
moved in a randomly chosen direction. The move was accepted if it
lowered the energy, and the move was accepted with Boltzmann
weighted probability if the energy increased. The main result of the
model was that the interaction between receptors can lead to a ﬁrst
order phase transition in the receptor density as a function of the
receptor chemical potential and/or the ligand concentration. In other
words, the receptor system will spontaneously form clusters of
receptors for a range of ligand concentrations. However, more detailed
features of the process, such as cluster structure and,more interestingly,
clustering dynamics were not addressed.
The last point was taken into consideration to some extent by a
recent model [94], in which it is supposed that the receptor is present
in the cell membrane in two forms (dimer and tetramer), and the
equilibrium between these species was analyzed. In the absence of
ligand the model predicts that the oligomeric arrangement of the
receptors depends on both their intrinsic propensity for oligomeriza-
tion and their cellular expression. Increasing their propensity to
interact, the receptor expression needed for changing the receptor
oligomerization degree from dimer to tetramer is lower. By contrast,
for higher values of expression the receptors are arranged mostly as a
tetramer even for those receptor species having a reduced tendency to
oligomerize. A ligand, however, can alter this equilibrium and act as a
positive oligomerizator, a negative oligomerizator or a neutral
oligomerizator, depending on the ligand-receptor dissociation con-
stants. Here, the term oligomerizator denotes a ligand able to alter the
intrinsic oligomerization equilibrium of a receptor system. An
example was provided by Vidi et al. [95] in a study showing that in
neuronal cells the treatment with D2 antagonists or with the A2A
agonist 5′-N-methylcarboxamidoadenosine (MECA) induced opposite
effects on the equilibrium between A2A/D2 and A2A/A2A dimeric forms.
In particular, decreased A2A/D2 relative to A2A/A2A oligomer formation
was observed following prolonged D2 stimulation. Since in this study
the drug-induced changes in oligomer formation were not readily
explained by alterations in receptor density, the observation sup-
ported the hypothesis that drug exposure differentially altered A2A
and D2 receptor oligomerization.
An interesting view on receptor cluster dynamics was provided by
Woolf and Linderman [96] in a model analyzing speciﬁc dimerization
occurring between receptors with only one speciﬁc binding site for
receptor–receptor interaction. The authors, however, hypothesized
that receptor dimerization could also have long-range ordering effects
via a ‘kiss and run’ mechanism [97]. In this view, each protein
competes to bind with its neighbours before they move too far apart
to interact. If the partner switching is fast relative to the diffusion rate,
then the receptors can effectively share a single bond between
multiple proteins and in doing so form clusters of proteins that extend
beyond a dimer pair. The ﬁndings of the study suggested that GPCRs
could exhibit dimerization-induced clustering and that such organi-
zation can in turn affect receptor signalling.
Recently proposed ﬂuorescence microscopy techniques (see
[98,99]) could represent a useful tool to test some of the above-
mentioned models. Total internal reﬂection ﬂuorescence (TFIRM)
imaging of single molecules was, for instance, used by Hern et al. [12]
to visualize M1 muscarinic acetylcholine receptors in CHO cells. By
tracking the position of individual receptors over time, their mobility,
clustering, and dimerization kinetics were directly determined. As in
the model by Woolf and Linderman [96], two colors TFIRM showed
the dynamic nature of dimer formation with M1 receptors undergoing
interconversion between monomers and dimers on the timescale of
seconds. At any given time, ~30% of the receptor molecules existed as
dimers, but no evidence of higher-order oligomers was found.
Fig. 3. Prediction of cooperative behaviour in a cluster of dimers of identical receptors
(RM) based on the “symmetry rule” [108]. A. In a cluster of dimers of identical receptors
(a tetramer in the example shown) only connections (dashed arrows) between
neighbouring monomers belonging to different dimers are considered. The possible
cooperative behaviour of the cluster is estimated by the function f, where the variables
x and y (representing the state of the monomers) can assume the value ‘0’ (unbound)
or ‘1’ (bound). In the last panel these values are represented with white and black
colour respectively. As shown, only “symmetrical matches” contribute to the overall
value of the cooperativity function, whereas other interactions do not affect it. B. If a
“symmetry rule” holds, the overall cooperativity will depend on the composition of the
RM, on the spatial arrangement of the dimers within the RM, and on the order of
activation of the monomers as well.
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A3 adenosine receptors by Cordeaux et al. [102]) indicate that the lipid
environment in which receptors are embedded (and in particular
Lipid Rafts) may also directly interact with the receptor heteromers
and homomers andmodulate their conformational state likely leading
to altered receptor–receptor interactions and thus altered integrative
signalling. Despite the increasing evidence, this aspect is usually
poorly taken into account when modelling the receptor interaction at
the plasma membrane level. The fundamental physical principles of
the lateral organization of membrane proteins were extensively
reviewed by Gil et al. [103]. In this study, based on a variety of
theoretical considerations andmodel calculations, the nature of lipid–
protein interactions was considered both for a single protein and for
an assembly of proteins that can lead to aggregation in the plane of
the membrane. Phenomena discussed included lipid sorting and
selectivity at protein surfaces, protein–lipid phase equilibria, lipid-
mediated protein–protein interactions, wetting and capillary con-
densation as means of protein organization, as well as non-
equilibrium organization of active proteins in membranes.
4. Dynamic behaviour of receptor mosaics
When mutual interactions between receptor proteins lead to the
formation of oligomers at the plasma membrane, they can work as
receptor mosaics. As a matter of fact, a RM has been deﬁned as an
assembly of receptors with direct physical interactions between them,
which has the following features [52,104]:
• A receptor assembly works as a RM if and only if at least one
receptor modulates via allosteric RRI the biochemical/functional
features of at least another receptor of the assembly.
• The ﬂuctuations of each receptor (of the RM) among its possible
conformational states are conditioned by the conformations of the
other receptors in the mosaic. Hence, each receptor will respond to
its ligand in a way that depends not only on its own conformation
but also on its allosteric interactions with the other receptors of the
macromolecular assembly.
• Given a certain stoichiometry of a RM vs. the dimeric condition, the
RRIs that take place obviously depend on the topology of the RM,
that is, on the spatial arrangement of the receptors forming the
assembly and on the efﬁcacy of the “allosteric pathways” [105–107]
interconnecting the receptors with each other.
These concepts were well illustrated by a simple mathematical
approach to the cooperativity in RM formed by dimers of identical
receptors and/or by receptors binding to the same ligand [108]. The
model is based on a “symmetry rule”, which has been proved for
haemoglobin [109], and maintains that a quaternary switching from
tense form (the “deoxy”, low afﬁnity state) to relaxed form (the “oxy”,
high afﬁnity state) occurs whenever haeme-site binding create a
tetramer with at least one ligated subunit on each dimeric half-
molecule. As shown in Fig. 3, when the same basic rule is applied to
RM formed by homodimers (as evidenced for dopamine receptors,
[110]) the integrative cooperativity of the RM appeared to depend not
only on RM composition (number of dimers), but also on its spatial
organization (respective location of the dimers) and order of
activation (order according to which the single receptors are ligated).
In the last years a number of computational models and computer
simulations allowed the investigation in more detail of the complex
cooperative behaviour of RM. They will be brieﬂy reviewed here.
4.1. Discrete dynamics based approach
As emphasized before, a receptor can assume multiple conforma-
tions. From a functional point of view, however, it is generally thought
[25,111] that they can be subdivided in two broad classes: (a) Inactive
conformations (R states, which can be also scored as conformation‘0’), characterized by a “low afﬁnity state” for the macromolecular
effectors. (b) Active conformations (R* states, which can also be
scored as conformation ‘1’), characterized by a “high afﬁnity state” for
the macromolecular effectors. Thus, as a ﬁrst approximation, the state
of each receptor can be simply described by a binary variable and the
pattern of 0 and 1 (or R and R*) across the whole mosaic is the
mosaic's conﬁguration at that moment in time. Such a conﬁguration
will change in the time as a result of the interactions each receptor
establishes with the micro-environment and in particular with
neighbouring receptors.
On this basis, at the “International Workshop on the role and
control of random events in biological systems”, held in Sigtuna
(Sweden) in 1995, Agnati and Fuxe proposed Boolean Networks (BN)
as a suitable abstract model for the study of the behaviour of a RM
[25,112]. BNs, indeed, are dynamic systems, composed of binary units,
in which each unit changes state in discrete time steps by the
application of a simple local rule (“switching rule”), i.e. based on the
states of a number of neighbouring units [113]. It was shown that BNs
provide a mathematical framework able to describe how complex
properties may emerge from systems characterized by deterministic
local interactions of many simple components acting in parallel [114].
An approach consistent with this line of reasoning was at the basis
of modelling efforts [111,115,116] to describe the bacterial sensing
leading to bacterial chemotaxis. In these models a cluster of two-state
receptors was considered in which a cooperative coupling among
receptors was present. Some constraints on topology (a 2D array) and
on the coupling between nearest neighbours allowed the reduction of
the model to the well known two-dimensional Ising model for
magnetism, which can be solved analytically.
A true BN-based model of RM, with no particular constraints both
on topology and on the coupling between receptor units, was
proposed by Agnati et al. [87]. The authors considered as an example
the RM formed by dopamine D2L receptors and consisting of a ring of
receptor proteins. This structure is schematically shown in Fig. 4A and
was hypothesized on the basis of atomic forcemicroscopy data [29]. In
that model the “switching rules” were derived from the simpler form
of the Hamiltonian available for systems in which each component
unit is coupled to a number of nearest neighbours and submitted to
the inﬂuence of external processes [117]. As detailed in Fig. 4B, this
Fig. 4. Boolean networkmodeling of a ring of receptors according to Agnati et al. [87]. A. The state of each receptor in the ring depends on its actual state (single headed arrow) and on
the states of the two close by receptors with which it interacts (double headed arrows). B. At each time step the state S of each unit is updated according to a binary function derived
from the simplest form of Hamiltonian holding for systems of this type (see [117]): the J coefﬁcients represent the RRIs, i.e. the strength of the coupling between receptors, while
other energy contributions are represented by the term E. Such a “switching rule” corresponds to a set of Boolean rules. The table shown provides an example. C. When started from
random conﬁgurations the system converges to one of a limited number of equilibrium conﬁgurations (or “attractors”). An example of basin of attraction is reported in the ﬁgure as a
“transition graph”, in which conﬁgurations are represented as dots linked to their successors and the direction of time is inward from the more external dots to the attractor located
at the center. As illustrated at the bottom, the estimated attractors were formed by a single conﬁguration, characterized by a number of units frozen in the active state (black circles).
D. This limited set of attractors inﬂuences the response of the ring to an incoming signal, leading to sigmoidal dose–response curves.
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suitable to analyze the behaviour of the RM in selected conditions by
computer simulation. The major ﬁndings of the model by Agnati et al.
[87] are illustrated in Fig. 4C–D and can be summarized as follows:
• When started from random conﬁgurations the system rapidly
converges to one of a limited number of temporary equilibrium
conﬁgurations or ‘attractors’ [114].
• These conﬁgurations are always characterized by the presence of
elements frozen in the active state. It was also hypothesized that
these patterns of cooperative behaviour could represent a further
mechanism to tune the synaptic weight, playing a role in learning
and memory [25,30].
• Very common ‘macroscopic’ properties of a receptor system, such as
a sigmoidal response curve to an extracellular ligand, simply emerge
as a result of this limited set of activation patterns and the sensitivity
can be modulated by changes in the topology and/or in the local
interactions between the receptor units forming the RM.
4.2. Thermodynamics based approach
The properties of an oligomer consisting of a closed ring of N
identical protomers were also investigated by Duke et al. [118] by
following a thermodynamic approach. As in the above described
models, in this formulation each protomer can exist in two distinct
conformational states (designated as ‘active’ and ‘inactive’), andmakesrapid stochastic transitions between these states, with probability
given by:
p∝e−ΔE =kT
where ΔE is the energy difference involved in the transition, k is the
Boltzmann constant and T the absolute temperature. The energy of a
protomer in the oligomer was in turn dependent on three energy
terms: the energy associated with its conﬁguration, the energy
associated with the binding of a ligand, and the energy due to the
coupling with adjacent protomers. On that basis a computer
simulation of the dynamics of the oligomer was devised. At any
given concentration of the ligand, the activity of the protomers in the
ring ﬂuctuates in time due to their individual stochastic ﬂipping and
the random binding and dissociation of ligand molecules. In the
absence of RRI each protomer ﬂips independently of its neighbours,
generating a random salt-and-pepper pattern. But with the introduc-
tion of a non-zero coupling energy conformational spread gives rise to
contiguous regions, or domains, in which all protomers have the same
state. It is noteworthy that this result is consistent with the behaviour
predicted by BN-based models (see above). Moreover, the canonical
Monod–Wyman–Changeux (MWC) and Koshland–Nemethy–Filmer
(KNF) models of cooperativity arose naturally from the principle of
conformational spread as limiting conditions in which either the
coupling energy or the activation energy (i.e. the energy difference
between ‘inactive’ and ‘active’ conformations) are allowed to become
Fig. 5. Examples of theoretical saturation curves, having the binding and interaction
constants indicated, and comparing the possible interaction geometries (shown at the
bottom) of a trimer [104]. As illustrated, although the curves were characterized by the
same set of constants, they showed a clear-cut dependence on the way the receptor
cluster was arranged.
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appears to be a natural extension of the familiar mechanism of
allostery. In this respect, a thoughtful mathematical modelling and
analysis proposed by Christopoulos and Kenakin [119] made apparent
that even the simplest scenario of a receptor dimer can provide scope
for a bewildering array of allosteric interactions occurring between
orthosteric binding sites.
A generic model for the behaviour of an oligomer of GPCRs has also
been provided (see [120]) based on a receptor with n subunits, and
this has been extended to include inactive and active states [121].
Other authors have generated simpler models following the same
general principles [122–124].
A thermodynamic approach to the analysis of a cluster of receptors
taking also into account its topological arrangement was recently
proposed by Agnati et al. [104]. The analysis was performed in the
framework of a sequential scheme for the binding of a ligand to a
multisubunit protein. For each binding step the following equilibrium
condition holds:
Ri½ 
Ri−1½  L½ 
=
ni
ni−1
e−ΔG
0
=RT
where L denotes the ligand, Ri the protein complex with i occupied
sites and ΔG0 is the change in free energy involved in the transition.
The multiplicity factor ni accounts for the number of ways to achieve i
occupied sites. As discussed before, the change in free energy can in
general be split in three terms. However, assuming that the
conformational transition of each subunit is concomitant with ligand
binding, each subunit was considered to have only two possible
conﬁgurations (F or ‘free’ and B or ‘bound’) and the contributions due
to ligand binding and conformational change were lumped together
taking the energy per binding event as the free energy difference per
subunit between the free and bound states. As far as the subunit–
subunit interactions are concerned, the interaction energies between
F–B and B–B pairs of interfaced subunits were considered. On that
basis, theoretical binding curves were derived for the different
arrangements available to a trimeric and a tetrameric RM of identical
subunits. They have the following general form (see also [125]):
B =
x
n
⋅ d½ln F xð Þð 
dx
=
x
n
⋅ 1
F xð Þ ⋅
dF xð Þ
dx
ð1Þ
where n is the number of subunits, and x is the product of the ligand
concentration and the binding constant (i.e. x=KL [L]). F(x) is a
characteristic function of the RM, which strongly depends on the way
the subunits are arranged (i.e. on its topology). For instance, according
to the analysis by Agnati et al. [104], for a trimer of identical subunits
we have:
F xð Þ = 1 + 3K2FBx + 3K2FBKBBx2 + K3BBx3 for a triangular trimer
F xð Þ = 1 + K2FB + 2KFB
 
x + K2FB + 2KFBKBB
 
x2 + K2BBx
3 for a linear trimer
where KFB and KBB express the interaction energy between F–B and B–
B pairs of interfaced subunits respectively. By using the Eq. (1) we
obtain theoretical binding curves of the type shown in Fig. 5,
indicating that the existence of RRI leads to a signiﬁcant dependence
of the RM response on the geometrical arrangement of the subunits
within the RM. Thus, this mathematical model suggests that
stoichiometry and topology should be considered as different and
complementary characteristics of a receptor cluster, both signiﬁcantly
inﬂuencing its response to an incoming ligand.
Of note is also a model speciﬁcally developed for the constitutively
dimeric glutamate mGlu5 receptor [126], with the aim to gain new
insights into the functioning of these complex receptors. The model,
however, may apply to any other receptor system composed of anextracellular agonist binding domain and a transmembrane functional
domain. In fact, a major point of interest of this approach is that it
takes into consideration both the extracellular ligand binding domain
and the domain responsible for G protein activation. The model
allowed not only for the quantiﬁcation of agonist efﬁcacy and potency
and the interpretation of pharmacologic curve proﬁles in mechanistic
terms, but also illustrated some of the advantages for a receptor of
being a dimer, predicting that the interdependence between binding
sites makes a dimeric receptor more efﬁcient than the sum of two
single monomers.
By using a mathematical approach [127], a further insight into the
functional signiﬁcance of GPCR oligomerization was very recently
suggested. GPCRs, as indicated by their name, signal through their
interaction and subsequent activation of G proteins. However, the
functioning of these receptors appears more complex than was
initially thought and additional accessory proteins play a role in the
signal transduction concert as pointed out above discussing the
concept of HMNs [26,33]. Thus, proteins other than G protein reported
to interact with GPCRs and potentially responsible for G protein-
independent signalling include β-arrestins, tyrosine kinases and PDZ-
domain containing proteins (see [128] for a review). The recently
proposed model by Rovira et al. [127] takes this aspect into
consideration and accommodates two major signalling pathways
arising from either an asymmetric (R*R) or symmetric (R*R*)
arrangement of the protomers within the ligand activated dimer.
Remarkably, the model was shown competent for explaining some
relevant experimental results, as, for instance, the dosage dependent
switch from G protein-coupled to G protein-independent signalling
[129]. This model together with the abovementioned ﬁndings can be
discussed in the frame of the HMN concept and of the signal
compartmentalization to explain a crucial problem of the decoding
process, namely the selection of few or even one intracellular
molecular pathway among the several ones that a complex Ligand-
GPCR can activate. Actually, concepts derived from classical investiga-
tions on neural network structural organization such as the ‘fringe’
and the ‘lateral inhibition’ concepts have been proposed together with
the newly introduced concept of ‘molecular diverter’ to investigate
such a crucial aspect [31].4.3. The “metabolic algorithm” as a possible tool to study the combined
action of RMs
A computational approach which arose from the way the living
cells process the chemical compounds in their compartmental
structure was introduced in 1998 by Gheorghe P un (see [130,131]),
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called “P systems”, simulating the transformation and transport of
chemical-like entities within and between the compartments of a
given cell-like environment. One of the basic ingredients of every P
system is the algorithm used to implement such a time evolution of
the simulated system. In this respect, a procedure called “metabolic
algorithm” was recently proposed [132,133]. This method is inspired
by the law of mass action. Thus, all the processes involved in a system
are translated in a set of rules in the form of chemical-like reactions,
each associated to a reactivity coefﬁcient (see Appendix A).
Such a characteristic could make this computational approach
particularly useful to simulate (at least qualitatively) complex
behaviours deriving from the combined action of RMs. In the
Appendix A we tried to illustrate this possibility by taking into
consideration the dynamics of glutamate and endocannabinoid (in
particular anandamide and 2-arachidonoyl-glycerol) transmission in
the presence of both D2–A2A–mGlu5 and D2–A2A–CB1 receptor trimers.
These two trimers were suggested to be both present in the dendritic
tree of the striatopallidal GABA neurons [20,134]. To understand the
integrative activity of these RMs, it should be remembered that D2
receptor activation by agonists increases the endocannabinoid levels
of anandamide (N-arachidonoylethanolamine, AEA) [135], and
inhibits glutamate [136] signalling in the striatum, while mGlu5
stimulation increases the endocannabinoid 2-arachidonoyl-glycerol
(2-AG) signalling in the striatum [137]. The existence of RRIs between
D2 and A2A, CB1, mGlu5 receptors, however, can lead to a tuning of the
different signals, which can represent a complex patternwith possible
interesting functional implications. The basic scheme is illustrated in a
highly simpliﬁed way in Fig. 6.
In particular, the results of the simple model outlined in the
Appendix A suggest that, even in the presence of a constant dopamine
transmission, the release of A2A signalling could make glutamate
transmission to dominate over the AEA signalling, leading to an
increased activity in the glutamate drive of the striatopallidal GABA
neurons. However, glutamate by activating mGlu5 can induce a
release of 2-AG but the global endocannabinoid levels may not vary
substantially. If the interactions, considered in a highly schematic and
simpliﬁed fashion in Fig. 6 represent at least in an approximate way
the signalling processes in the restricted volume of striatal tissue
affected by the integrative actions of these two trimeric RMs, it is
possible to surmise the following:
- The results of the model further suggests a role of hub receptor
[104] for the adenosine A2A receptor in the D2-A2A-mGlu5 and D2–
A2A–CB1 receptor trimers;Fig. 6. Schematic simpliﬁed representation of the system formed by D2–A2A–CB1 and
D2–A2A–mGlu5 trimers. Dashed and solid arrows represent inhibitory and stimulatory
interactions respectively (see [33]). D2 receptor activation by agonists (dopamine, DA)
increases anandamide (AEA), and inhibits glutamate (GLU) signalling, which, in turn,
enhances 2-arachidonoyl-glycerol (2-GA) transmission. D2 function, however, is also
under the control of the other receptors in the trimers, leading to an integrated
behaviour.- A2A receptors are part of trimers whose integrative mechanism
could represent an inhibitory feedback mechanism to reduce
exaggerated and prolonged activation of D2 receptors withmarked
prolonged silencing of the striatopallidal GABA neurons, and
potential development of involuntary movements [138];
- Endocannabinoid global levels are basically kept constant, and this
datum can suggest a special role for such a signalling system,
possibly related also to its peculiar space of diffusion (i.e., also the
intracellular space) and hence to its multiple possible targets;
- The ratio between AEA and 2-AG can vary according to the
differential activations of the two trimers and these oscillations
may have an informational value representing an integrated signal
of the actual functional state of the two trimers and in particular of
the A2A receptors.
Obviously these are speculations, but are in agreementwith available
data and from a general standpoint show the potentially complex cross-
talk of trimers in regulating signalling in a certain brain volume.
5. Concluding remarks
The growing experimental evidence showing that GPCR dimer-
ization/oligomerization has pharmacological and functional implica-
tions (see [27,139–141] for reviews), opened a series of new research
lines, which found in bioinformatics and mathematical modelling
fundamental supporting tools.
A ﬁrst question to address [15] was the search for detailed
structural information on the receptor–receptor interaction inter-
faces, in order to enable a mechanistic understanding of these
complex biological systems. It has to be observed [23] that most
experimental methods used so far to study GPCR dimerization/
oligomerization, such as co-expression, coimmunoprecipitation, and
resonance energy transfer (BRET, FRET), do not reveal the details of
the GPCR interaction interface(s). In this respect, computational
modelling and bioinformatics provided valuable hypotheses for the
experimental exploration of interfaces between GPCRs. In fact, they
are now considered a key component of an iterative protocol of
computational prediction and experimental validation (see [76]),
which was proven quite successful (see [85]). In this process of
enquiry, results from the analysis of sequence data are used to guide
the construction of 3D models of GPCR homo- and heterodimers, and
inferences from these models are then implemented in the design of
experiments (e.g. the design of dimerization-disrupting mutants) to
probe, validate, and reﬁne the hypotheses of interaction between
monomers. Notably, as summarized in Table 4, many bioinformatic
predictions were conﬁrmed by the available experimental data.
A second important question [142] is why do receptors form
dimers? Or more generally, why is the GPCR dimerization/oligomer-
isation phenomenon so widespread?
Milligan considered the possibility of a facilitation of G protein
activation. This does not seem to be the real reason of oligomerization,
since the GPCR dimerization does not appear to be a general
requirement for intracellular signal generation, since a single GPCR
has been shown to signal efﬁciently to G proteins [5,6]. However, a
result from themodel by Rovira et al. [126] (see Section 4.2) opens the
possibility that the efﬁciency of a dimer could be higher than the
efﬁciency exhibited by the two single monomers, while another
model [127] suggested that GPCR dimerization could play a role in the
observed [129] dependence on ligand concentration of the switching
from G protein-coupled to G protein-independent signalling, These
hypotheses remain to be tested.
Lohse [143] made the interesting suggestion that among the
possible functional effects of receptor dimerization a cross regulation
in cell surface mobility should be considered. Consistent with this
hypothesis is the mathematical model by Woolf and Linderman [96],
illustrating a simple mechanism potentially allowing the receptor
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Notably, the same mechanism could also trigger dimerization-induced
clustering, with potential consequences on signalling (see Section 4).
These aspects should be considered in the frame of the complex
biophysical organization of the plasma membrane (see above).
Our group has put forward some other reasons that can be
suggested to explain a possible important role for receptor oligomer-
ization and hence for the existence of RMs. Thus, the main functional
implications of the RRIs can be summarized as follows:
• To have negative or positive cooperativity in homomers with a great
spectrum of different strengths [26]. In particular, different assemblies
of receptors can take advantage not only of different stoichiometry,
but also of different topologies with the same stoichiometry, as
suggested by mathematical models [104,125] exploring the differ-
ent conﬁgurations (see Section 4.2).
• The possibility to have a preliminary elaboration of the information
already at membrane level. This elaboration could either ﬁlter the
relevant signals that in fact reach the downstream signalling
pathways and/or give integrated signals to these molecular net-
works. The basic mechanism for such an elaboration can be RRI-
induced conformational spread, as suggested by a number of
mathematical models here reviewed [87,118]. A very interesting
case of such a ﬁltering process is the one experimentally observed
by Vilardaga, Lohse and collaborators of a direct trans-inhibition by
MOR of α2A-AR which can also help explain previously described
antagonistic NPYR-alpha2 receptor–receptor interactions at the
membrane level (see [138,144,145]). Thus, morphine binding to the
MOR triggers a conformational change in the norepinephrine-
occupiedα2-AR that inhibits its signalling to Gi and the downstream
MAP kinase cascade. It has been assessed that the cross-conforma-
tional switch that permits direct inhibition of one receptor by the
other in the heteromer occurs with sub-second kinetics. In other
words, the allosteric signal propagates over the receptor interface to
induce its conformational changes, which are of high functional
relevance [119,138]. In particular, the ﬁnding obtained by different
mathematical approaches that the oligomer dynamics in given
conditions could be characterized by a limited spectrum of speciﬁc
attractors (see Section 4.1), led to the proposal that RMs could play
an important role in the modulation of the “synaptic weight” and
thus in the process of learning and memory [25,27,30,146].
• The existence of micro-domains at plasma membrane level where
integrations of extracellular and intracellular signals occur also
thanks RMs [26,29]. This aspect may be of the highest importance
for the existence of “hot domains” in the plasma membrane
(“signallosomes” [147]), e.g., devoted to the recognition/decoding
of Volume Transmission (VT) signals (see [148–150]). Actually,
dendritic spines for which a presynaptic side is not detectable, can
be surmised as being specialized regions where RMs devoted to the
VT are especially located. Also based on the suggestion from
mathematical modelling [87], it has been surmised that receptors
in these RMs use a ‘positive cooperative’ mechanism to detect the
low concentrations of the VT-signals.
• The matching between two topologically organized multimeric com-
plexes: the receptor mosaics and the aggregated G proteins as
suggested by Rodbell [151]. This arrangement is potentially capable
of unexplored mechanisms of control such as a regulation of the
composition of the G-protein chain and the progression of the G-
proteins of the chain in contact with a GPCR of the RM that can be
changed according to some control signalling [28].
Finally, in the present paper it has been shown that two similar
trimers, namely D2–A2A–mGlu5 and D2–A2A–CB1 can operate in concert
to regulate signalling in restricted brain volumes. Thus, two signals
(glutamate and endocannabinoids) may be co-regulated leading to the
functionally important consequences mentioned above. This co-
regulation has been illustrated by a simple mathematical approach,focused on the integrative action of the two receptor trimers. The
analysis of the speciﬁc case here considered suggested a possible key
role for adenosine as a regulator of glutamate transmission in the
striatopallidal GABA neurons, even in the presence of constant
dopaminergic signalling. It should be noted that in analyzing these
two trimers it has also been possible to speculate that the adenosine A2A
receptor may play the role of ‘hub receptor’ [26,33] within the trimers.
A third key question is in which cell compartment the GPCR
aggregation occurs. In principle, it is possible to distinguish three
environments where biochemical processes relevant for receptor
aggregation can take place:
1. The endoplasmic reticulum–Golgi apparatus: sites of protein
synthesis and modiﬁcations.
2. The trafﬁcking to the plasma membrane: this process can often
take place thanks to chaperons and/or endosomes [152,153].
3. The plasma membrane: it should be noted that the plasma
membrane is a heterogeneous structure from a biochemical and
biophysical standpoint. This heterogeneity could deeply affect
GPCR three-dimensional structure and hence interfaces for RRIs as
well as electrostatic interactions between their polar residues.
As a ﬁnal comment it should be underlined that the processes
mentioned above are not mutually exclusive rather they can be
functionally linked together. In particular, processes taking place in
the two ﬁrst steps can determine the membrane micro-environment
where eventually GPCRs will be localized. This question remains largely
to be addressed both from an experimental and a computational point of
view. Thus, it could represent a signiﬁcant line of future development.
In conclusion, the present paper shows the reciprocal fertilising
interactions between experimental investigations on GPCR structure
and functions and a bioinformatic analysis associated whenever
possible to a mathematical modelling of the integrative action of RMs.
Such a close collaboration established between experimental and
computational approaches should allow a further success in getting a
better understanding of the physiological relevance of receptor–
receptor interaction and GPCR oligomerization, in testing hypotheses,
and in deriving suggestions for new experimental tests.
Appendix A
A possible mathematical approach to describe processes resulting
from the complex behaviour of RMs acting in concert will be here
brieﬂy outlined.
In particular, we shall refer to the modulation of glutamate and
endocannabinoid transmission resulting from the possible interplay
of D2–A2A–mGlu5 and D2–A2A–CB1 receptor trimers, which were
proposed to be both present in the dendritic tree of the striatopallidal
GABA neurons [20,134].
Method
The general method applied will be the so-called metabolic
algorithm [132,133], a method inspired by the law of mass action
(stating that the driving force of a transformation is directly
proportional to the active masses of all the interacting elements).
According to this method, all the processes involved in a system are
translated in a set of rules in the form of chemical-like reactions, each
associated to a reactivity coefﬁcient. Let us consider, for instance, the
following set of rules:
r1 : AC→AB :k1
r2 : BC→A : k2:
That means that the ﬁrst rule, r1, says that a unit of A interacting
with a unit of C, produces a unit of A and a unit of B. Every rule can
r1: T1 DA→T*1 DA k1 Activation of A2A–D2–mGlu5 trimer
r2: T*1 A→T1 A k2 Inactivation of A2A–D2–mGlu5 trimer by adenosine
r3: T2 DA→T*2 DA k3 Activation of A2A–D2–CB1 trimer
r4: T*2 AEA→T2 AEA k4 Inactivation of A2A–D2–CB1 trimer by anandamide
r5: T*2 2GA→T2 2GA k5 Inactivation of A2A–D2–CB1 trimer by 2–GA
r6: T*2 A→T2 A k6 Inactivation of A2A–D2–CB1 trimer by adenosine
r7: T*1→T*1 AEA k7 Increase of AEA signalling when D2 is
operating in the A2A–D2–mGlu5 trimer
r8: T*2→T*2 AEA k8 Increase of AEA signalling when D2 is
operating in the A2A–D2–CB1 trimer
r9: T1→T1 G k9 Increase of glutamate signalling when D2 is
inhibited in the A2A–D2–mGlu5 trimer
r10: G→G 2GA k10 Increase of 2-GA signalling induced by glutamate
r11: γ G→γ k11 glutamate inactivation mechanisms
r12: η AEA→η k12 AEA inactivation mechanisms
r13: θ 2AG→θ k13 2-AG inactivation mechanisms
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whole set of rules has to be considered to describe the trend of the
amount of a component in time.
The variation of the amount of a component due to the application
of a rule is deﬁned as the difference between the amount of the
component before the execution of the rule and that after it.
For example, let's compute the variation Δr1C on object C due to
rule r1. By looking at rule r1, we see that C doesn't appear in the
products part of the rule and it's not hard to understand that the
application of the rule decreases the amount of C in the system (while
symmetrically increasing the concentration of B). Thus, we shall have:
Δr1C = −k1dAdC
where k1 is the reactivity coefﬁcient of the rule r1. Similarly, the
variations on A and B due to rule r1 will be:
Δr1A = 0
Δr1B = k1dAdC
In order to calculate the overall variation on the amount of an
object during a step of the simulation, we have to sum over all the
variations induced by every rule:
ΔX = ∑
r∈R
ΔrX
Thus, for the example system above we shall have:
ΔA = k2BC
ΔB = k1AC–k2BC
ΔC = −k1AC–k2BC
which is a system of 3 ﬁnite differences equations describing the
evolution of the example system considered.
Simulation
The system to test by simulation was described in Section 4.3, and
is schematically shown in Fig. 6 It can be characterized by the
following set of components:
X = T1;T*1;T2;T*2;G;AEA;2GA;DA;A;γ;η;θf g
where:
T1 D2–A2A–mGlu5 trimer in inactive state (i.e. with inhibited
dopaminergic transmission)Fig. 7. A. Time course of themodelled glutamate (Glu), anandamide (AEA) and2-arachidonoyl-g
adenosine signalling were applied to the modelled system and the plateau values of glutama
adenosine signal levels. As illustrated, under the assumptions of the model (see text) adenosin
lines (left panel). Moreover, as shown in the right panel, this change in AEA to 2-AG ratio oc
simulated systems.T*1 D2–A2A–mGlu5 trimer in active state (i.e. with operating
dopaminergic transmission)
T2 D2–A2A–CB1 trimer in inactive state (i.e. with inhibited
dopaminergic transmission)
T*2 D2–A2A–CB1 trimer in active state (i.e. with operating
dopaminergic transmission)
G glutamate signalling
AEA anandamide signalling
2GA 2-arachidonoyl-glycerol (2-GA) signalling
DA dopamine signalling
A adenosine signalling
γ Intra and extracellular mechanisms inactivating glutamate
signalling
η Intra and extracellular mechanisms inactivating ananda-
mide signalling
θ Intra and extracellular mechanisms inactivating 2-GA
signalling
and the following set of “reactions” was deﬁned:They lead to the following system of equations:
ΔT*1 = k1T1DA–k2T*1A
ΔT1 = k2T*1A–k1T1DA
ΔT*2 = k3T2DA–k4T*2AEA–k5T*22GA–k6T*2A
ΔT2 = k4T*2AEA + k5T*22GA + k6T*2A–k3T2DA
ΔG = k9 T1–k11G
ΔAEA = k7T*1 + k8T*2–k12AEA
Δ2GA = k10T1–k132GA
ΔDA = 0
ΔA = 0:lycerol (2-AG) signallingwith adenosine signalling set to a low level. B. Increasing levels of
te, AEA and 2-AG signalling were recorded. They are shown plotted as a function of the
e behaved as a switch, which inverts the relative incidence of AEA and 2-AG transmission
curs keeping almost constant the global level of endocannabinoids (AEA+2-AG) in the
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not assumed to change during each simulation: they will be used
as independent variables. In particular, in the performed simula-
tions the dopamine signalling was kept constant and the behaviour
of the system was tested for different conditions of adenosine
stimulation.
As far as the reactivity constants ki are concerned, they range
between 0 and 1. However, no experimental data exist suggesting a
choice for their values. Thus, it was simply assumed that the reactivity
constants driving the activation of the trimers by dopamine (i.e. k1
and k3) were greater than the constants driving the inactivation by
the other receptors in the trimers (k2, k4, k5, and k6). All the other
constants were set at a value around the middle of the possible range
(i.e. k≈0.5). Such an arbitrary (but reasonable) condition was kept
ﬁxed in all the simulations performed.
The open source software platform for numerical computation
SCILAB 5.2.0 (The SCILAB Consortium, France, www.scilab.org) was
used to develop the model and to solve the corresponding equations.
The results of the performed simulations are summarized in Fig. 7.
As illustrated, they suggest that, even under stable conditions of
dopamine signalling, the relative importance of 2-AG (reﬂecting
glutamate signalling) and AEA transmission could be signiﬁcantly
modulated by adenosine, exploiting the inhibitory RRIs between A2A
and D2 receptors in the trimeric RMs.
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